Biomarkers of Alzheimer's disease among Mexican Americans. - Test2 - elhamkhani - TriplyDB

Biomarkers of Alzheimer's disease among Mexican Americans.

Biomarkers of Alzheimer's disease among Mexican Americans.

http://www.wikidata.org/entity/Q36716970

about

Comparing biological markers of Alzheimer's disease across blood fraction and platforms: Comparing apples to oranges Oxidative stress, testosterone, and cognition among Caucasian and Mexican-American men with and without Alzheimer's disease Validation of a serum screen for Alzheimer's disease across assay platforms, species, and tissues.Association of Pancreatic Polypeptide with Mild Cognitive Impairment Varies by APOE ε4 Allele.Thrombopoietin is associated with δ's intercept, and only in Non-Hispanic Whites Identifying postmenopausal women at risk for cognitive decline within a healthy cohort using a panel of clinical metabolic indicators: potential for detecting an at-Alzheimer's risk metabolic phenotype Changes in the plasma proteome at asymptomatic and symptomatic stages of autosomal dominant Alzheimer's disease A blood screening test for Alzheimer's disease Serum-based protein profiles of Alzheimer's disease and mild cognitive impairment in elderly Hispanics.δ scores predict mild cognitive impairment and Alzheimer's disease conversions from nondemented states.The Hachinski ischemic scale and cognition: the influence of ethnicity.Amyloid-β induces sleep fragmentation that is rescued by fatty acid binding proteins in Drosophila.Exportation and Validation of Latent Constructs for Dementia Case Finding in a Mexican American Population-based Cohort.Texas Mexican American adult normative studies: Normative data for commonly used clinical neuropsychological measures for English- and Spanish-speakers.Cerebrospinal fluid and blood biomarkers for neurodegenerative dementias: An update of the Consensus of the Task Force on Biological Markers in Psychiatry of the World Federation of Societies of Biological Psychiatry.Alzheimer's Disease: A Journey from Amyloid Peptides and Oxidative Stress, to Biomarker Technologies and Disease Prevention Strategies-Gains from AIBL and DIAN Cohort Studies.Impaired Cerebral Vasomotor Reactivity in Alzheimer's Disease Non-beta-amyloid/tau cerebrospinal fluid markers inform staging and progression in Alzheimer's disease

P2860

Q24289443-65F90C39-8A9C-4776-978B-E554F67A0D06 Q34449460-13400FFB-1A85-4ED6-9AB8-FBEDA6B6688B Q35456060-7D94E929-E597-4530-A7B0-16847FA1EFE7 Q36033650-C432DE74-D0D8-4FBF-8DEB-F2D790C70F1B Q36934167-23256322-E78F-4D6F-A27C-7FDD27BD1345 Q37038430-94E61671-6185-4231-B332-E2DEB56A77E1 Q37067687-265A06E3-CE57-4D84-89D8-82696AA72605 Q37085325-F0248603-71BB-485F-925B-5063E4DD944F Q37342809-1A1D4F03-F22B-4E17-85A3-5BFA133D0368 Q37725134-6C73F91E-06C3-46E3-91B7-0EC2471B8621 Q37725833-C925AAE0-B84D-4377-8F7E-FBBF8A20972B Q38851223-6EEA1523-32A3-49CF-A191-84A69442465C Q39927774-D9F3DB46-2194-4FA2-8B78-82ECD16E760B Q47391588-691073EA-6A93-41FE-A147-8707FCFCD31A Q47587631-99D2773A-15CE-49E5-9497-6ED708A86F50 Q51760876-709B9BAF-FA33-4681-90F1-96C21E3E23B4 Q57115718-402730E9-BFEF-414D-9FC5-397FE81AFC7A Q58698516-4FD404DB-61EC-4478-A1A5-9D38597E91CD

P2860

Biomarkers of Alzheimer's disease among Mexican Americans.

http://www.wikidata.org/entity/Q36716970

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

2013年论文

@zh

2013年论文

@zh-cn

name

Biomarkers of Alzheimer's disease among Mexican Americans.

@ast

Biomarkers of Alzheimer's disease among Mexican Americans.

@en

type

label

Biomarkers of Alzheimer's disease among Mexican Americans.

@ast

Biomarkers of Alzheimer's disease among Mexican Americans.

@en

prefLabel

Biomarkers of Alzheimer's disease among Mexican Americans.

@ast

Biomarkers of Alzheimer's disease among Mexican Americans.

@en

P1433

Q36716970-84BD1B6C-0FE3-4923-AB73-52CC3050F2A8

P1476

Q36716970-6D28F2D0-5AE5-4F77-B2A1-06D0C7EE6C24

P2093

Q36716970-12EBB366-9448-4E65-8FCF-29A7FBDDE77D

Q36716970-2F38DDAC-C50C-473C-95F6-117AB625B57C

Q36716970-5D8FE8FF-CEFF-4A0F-B370-134C40CE6CFE

Q36716970-AD606705-4B55-46BE-8A1D-8D99215FDDCF

Q36716970-EA7AFB28-2BFE-49DC-9868-229F04A784B2

Q36716970-F193B768-6DB7-40D4-8249-F03B499EB7CE

Q36716970-F4610336-C718-44BA-AC31-B0988B14BE39

P2860

Q36716970-00A08A24-E7B1-4A1A-8315-4E8CA5AF6AB5

Q36716970-03B163EA-121F-4456-A035-5CDB931D7F64

Q36716970-1CBDE546-CE6E-4BB2-9419-CD4CEF085FB8

Q36716970-262420B4-BAAD-4FC5-85A5-5583FBCEB938

Q36716970-26BC141A-ED86-4504-9022-806190EBB050

Q36716970-28528DF0-4E57-460A-9765-1BBEAF0ED6A3

Q36716970-2AAA1866-E128-4DA7-A761-674869864BFA

Q36716970-2F905C58-5D14-462C-9306-97E9A3C2FA57

Q36716970-35D0D853-6D72-49D6-9FE2-71CC06CFA0F5

Q36716970-39462B10-1F34-4488-BC77-77159AE0E551

P304

Q36716970-EDC8191E-2830-419F-A261-5CE30E2CDDC5

P31

Q36716970-526B9A3E-97DF-4091-9ECD-DA8BE31D8804

P356

Q36716970-1A594DCA-1A61-4F63-BE71-DE70C4EBDBE6

P433

Q36716970-7C873F6C-D8BA-4AA8-A16A-F2E183C7492B

P478

Q36716970-D1933AD2-F403-498E-AB07-3103588608A7

P50

Q36716970-65E8AA2E-BAAC-41B3-A6BA-047A447D0A65

Q36716970-C0F70723-9659-4F2B-950D-C32C077EB780

P577

Q36716970-27E4C227-95FB-40DD-8939-D90AF5616F38

P698

Q36716970-88C4516E-4D4C-4ED6-B990-33CB8502038A

P921

Q36716970-47191184-2457-4E3C-81F2-C057A246BB08

Q36716970-80A13DDB-A0A2-4892-A867-FA08505908B6

P932

Q36716970-CC44E44F-FA6B-48C8-A901-5000D7CF32AF

P356

P1433

Journal of Alzheimer's Disease

P1476

Biomarkers of Alzheimer's disease among Mexican Americans

@en

P2093

Fan Zhang

http://www.w3.org/2001/XMLSchema#string

Guanghua Xiao

http://www.w3.org/2001/XMLSchema#string

Melissa Edwards

http://www.w3.org/2001/XMLSchema#string

Michael Devous

http://www.w3.org/2001/XMLSchema#string

Robert Barber

http://www.w3.org/2001/XMLSchema#string

Texas Alzheimer's Research and Care Consortium (TARCC)

http://www.w3.org/2001/XMLSchema#string

Veer Bala Gupta

http://www.w3.org/2001/XMLSchema#string

P2860

Biological markers of amyloid beta-related mechanisms in Alzheimer's disease

Identification of candidate IgG biomarkers for Alzheimer's disease via combinatorial library screening

“Mini-mental state”

Gut-central nervous system axis is a target for nutritional therapies

A blood-based screening tool for Alzheimer's disease that spans serum and plasma: findings from TARC and ADNI

Diagnosis of Alzheimer's disease based on disease-specific autoantibody profiles in human sera

The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey

The Clinical Dementia Rating (CDR): current version and scoring rules

The use of neurophysiological endophenotypes to understand the genetic basis of schizophrenia.

P304

841-849

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3233/JAD-122074

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

34

http://www.w3.org/2001/XMLSchema#string

P50

P577

2013-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23313927

http://www.w3.org/2001/XMLSchema#string

P921

Alzheimer's disease

P932

3608404

http://www.w3.org/2001/XMLSchema#string